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Abstract
The prevailing viewpoint on children with rare trisomy conditions 
such as trisomy 18 (t18) and trisomy 13 (t13) is almost uniformly 
negative. Yet, case studies offer information about long-term 
survivors. What is missing in the discussion is an unbiased 
examination of surviving children within the context of necessary, 
rather than “aggressive”, medical interventions and overall quality 
of life. A move beyond palliative or comfort care must be an option 
for this population. There must be a move toward valuation of 
life and corresponding provision of treatment and examination of 
developmental gains rather than limited intervention or palliative 
care for infants with lethal fetal abnormalities. This article presents 
a call to examine the individual child rather than decision making by 
diagnosis framed by recommendations from the Convention on the 
Rights of the Child (CRC) and Convention on the Rights of Persons 
with Disabilities (CRPD) Medical professionals and parents must 
work together to ensure medical needs are met and a positive 
quality of life can be achieved. 
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The prevailing viewpoint on children with rare trisomy conditions 
such as trisomy 18 (t18) and trisomy 13 (t13) is almost uniformly 
negative. Population based studies describe low survival rates for 
infants commonly labeled as possessing “lethal fetal anomalies” or 
who are considered “incompatible with life” [1-6]. Yet, case studies 
are available highlighting long-term survival [7] as well as parents 
sharing their experiences online via blogs and Facebook. The paradox 
is clear. Studies describing large number of children are bleak 
while individual cases are more positive. The majority of medical 
professionals look to the former while parents the latter. This often 
brings conflict when parents request medical interventions such 
as surgery for their children [8,9]. An additional factor is a rise in 
prenatal testing and diagnosis. Often, when t18 or t13 is confirmed, 
parents receive recommendations for termination [10,11]. 
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What is missing in the current discussion is an unbiased 
examination of surviving children within the context of necessary, 
rather than “aggressive”, medical interventions and overall quality 
of life. Writers in the areas of palliative care and bioethics largely 
recommend limited medical intervention or only the provision of 
comfort care for this population [12-16]. 
This author undertook a review of the current literature to 
examine current perspectives on the topic. The parameters were 
articles related to newborn palliative care in general and focused on 
rare trisomy conditions and also key articles from the past decade 
concerning fetal outcomes related to t18 and t13. Abstracts were then 
reviewed to verify content. Author searches were also conducted. 
Finally, recommendations from professional colleagues were sought. 
Resulting articles and authors suggestions were followed up if not 
already located with the above described methods. Key quotations 
were also identified for inclusion in this article. 
Current Perspectives
Little valuation of life is evidenced in the recommendations of 
Goc et al. [14]. The authors do not recommend caesarean sections 
or surgery in the immediate postnatal period for newborns with 
t18. This is in the face of multiple reports such as those from Japan 
of children living past the age of one year with positive surgical 
outcomes [17-19]. In addition, at the present time, there is very little 
literature on developmental outcomes [20,21]. This further impacts 
and reinforces the prevailing view that focuses on a limited quality 
of life and arguments against aggressive care [11-13,15]. There must 
be a move toward valuation of life and corresponding provision of 
treatment and examination of developmental gains rather than 
limited intervention or palliative care for infants with “lethal” or 
“severe” fetal abnormalities. 
Concurrently, a significant article by Brown and Guralnick 
[22] was published stating the importance of components of the 
Convention on the Rights of the Child (CRC) and Convention on the 
Rights of Persons with Disabilities (CRPD). For this article’s emphasis 
on advocating for treatment of children with rare trisomy conditions, 
several points are particularly significant including:
[Article 8: Raising awareness] emphasizes the importance of 
addressing systemic discriminatory attitudes toward individuals with 
disabilities, a reality that exists around the world. To that end, the 
CRPD calls upon States Parties to raise awareness throughout society, 
including within the family, regarding the rights of individuals with 
disabilities in order ‘to combat stereotypes, prejudices and harmful 
practices’ as well as to develop positive media campaigns and other 
awareness programs (p. 278).
This is in marked contrast to much of the published work in 
neonatal nursing and palliative care [8,23-25]. There is discussion of 
induced abortion and feticide for infants with a severe fetal anomaly 
such as t18 or t13. Chervanek and McCullough [26] explain “We 
define ‘severe’ abnormalities as…compatible with survival in some 
cases but result in virtual absence of cognitive function, e.g. trisomy 
18…the potential for cognitive development – and therefore the 
achievement of human and social goods, e.g. relationships with others 
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– are virtually absent” (p. 255). It appears that the authors have not 
reviewed the case studies or experienced contact with living infants 
and children with t18 or t13. As this author can attest, cognition may 
be significantly impaired but interactions and relationships with 
parents, siblings and significant others (e.g., grandparents, teachers) 
are evidenced in a variety of ways including eye contact, smiling, 
laughing, reaching and vocalizing by children with these conditions. 
Everett and Albersheim [27] describe Baby Smith, an infant with 
t18. The authors describe a framework to “…increase transparency, 
dialogue, understanding, and trust, which, in turn, may achieve 
greater consensus” (p. 55) for medical care decision making. The 
medical team refused to intubate Baby Smith and did not aggressively 
treat his unspecified cardiac condition. The infant passed away on the 
82nd day of life. What is most disheartening in this case study is the 
lack of value placed on the infant’s life and his parents’ wishes for 
more aggressive treatment. This is also evidenced in the care decisions 
presented by Bruns and Crosier [28]. The infant, Simon, passed away 
on the 88th day of life. As the case study indicates, quality of life is 
only partially dependent on length and medical needs. The infant 
encountered many difficulties during his brief life but all who came 
into contact with him were positively affected including medical 
professionals such as neonatal nurses and a pediatric cardiologist. 
Their views on medical treatments changed as a result of caring for 
Simon. 
Interestingly, a study by Carey [29] of neonatologists’ views 
on resuscitation of newborns with t18 states “It is critical that the 
emphasis should remain on fostering the best interest of the infant 
at every branch of the treatment decision tree” (p. 1109). Yet, this 
positive outlook is tempered by the authors’ recommendation that 
“Infants with lethal congenital anomalies and profound neurologic 
impairment continue to have immense inherent worth as human 
beings, and these infants are without doubt as deserving of love, care, 
and dignity as any child”. However, we contend that having intensive 
care measures such as intubation and corrective surgery available as 
potential options for infants with a confirmed lethal trisomy gives 
the impression to parents that these are reasonable interventions to 
consider…” (p. 1108). 
It is puzzling how both viewpoints can co-exist in terms of 
identifying treatment options and reinforcing the notion of “lethal 
congenital anomalies”. The authors offer some positive views on 
decision making but reinforce the negative stance of many in the 
palliative care field [9,12,15,16,27].
The literature reinforces the statistic of only 10% of affected 
infants reaching their first birthday. This percentage is often cited 
to parents at the time of prenatal diagnosis [2,6,13]. Yet, the 10% 
amount does not grant the authors cited here exclusive emphasis on 
the 90% of non-survivors. Investigations into differences between 
long-term survivors and non-survivors are absent. There is a dearth 
of information concerning characteristics of infants who die prior to 
one month, for example, compared with those living between one and 
three years. Analyses of these data are especially needed in the face of 
recommendations for comfort care at birth and palliative care after 
the immediate newborn period. 
Koogler et al. [30] point out, parents should be presented with all 
possible outcomes to arrive at informed decisions on their infant’s 
behalf rather than being told their infant has a lethal anomaly and 
should not receive care. In order for guidelines for decision making 
to be developed, there is a necessity to gather more extensive data 
(population-based and directly from parents and caregivers), build 
consensus and, only then, offer recommendations. In fact, Janvier et 
al. [31] describe positive perspectives from parents coupled with the 
need to learn more about their experiences raising children with rare 
trisomy conditions. Without these voices, there will be a continued 
emphasis on comfort care and non-treatment. 
Offering a Positive Viewpoint and Associated 
Recommendations
In this author’s experience, infants with t18 and t13 can and do 
flourish after cardiac repair and similar types of aggressive medical 
intervention [21,32]. Along with this data, there is a concomitant 
need to examine the needs of individual children rather than over-
reliance on statistical information for decision making. Data collected 
for the Tracking Rare Incidence Syndromes (TRIS) project includes 
multiple data points on medical needs and services and developmental 
outcomes. Two children in the TRIS database are described below: 
Annabel was born in March 2005 at 40 weeks gestation via 
planned c-section. She weighed 1986 grams. Medical issues at birth 
included respiratory difficulties, heart murmur, ASD, VSD, feeding 
difficulties and jaundice. She was diagnosed with trisomy 18, 11 days 
after birth. Currently, Annabel’s most pressing issues are kidney and 
liver functioning as well as related to feeding including PICC and 
central line concerns. Annabel had ureteral replantation surgery 
at 19 months. She currently receives medical care in the areas of 
cardiology, dermatology, gastroenterology, genetics, ophthalmology, 
pulmonology, and urology. Annabel imitates simple gestures. 
Annabel associates names of objects with their representation. She 
also displays preferences for familiar adults. 
Arianna was born in June 2006 at 39 weeks gestation via vaginal 
birth. She weighed 2781 grams. Medical issues at birth included 
respiratory difficulties, ASD, PDA, VSD, feeding difficulties, and 
jaundice. She was diagnosed at three days. Arianna required oxygen 
until the spring of 2012. She is fed via a G-tube. She is also diagnosed 
with hyperopia and conductive hearing loss. At seven months of 
age, Arianna had cranial stenososis surgery. She also had her tonsils 
and adenoids removed at 23 months. Arianna indicates preferences 
for familiar adults and uses her hands to explore objects. She also 
interacts during social games. 
It is important to note that both children were diagnosed 
postnatally. “Soft markers” were not identified for Annabel but 
were present for Arianna. Her family did not consider termination 
due to their religious beliefs. There is also much additional data on 
both children describing educational and therapy services and use of 
assistive items such as a gait trainer and augmentative communication 
devices. 
Most current literature does not provide this type of in-depth 
discussion of long-term survivors and generally reinforces the 
findings on early death or negative outcomes. Yet, this information 
is needed to expand the current knowledge base for professionals 
and provide parents with more positive, yet realistic (e.g., surgeries, 
chronic conditions), outcomes. Annabel and Arianna’s famililes do 
not focus on what their daughters cannot do or compare her to their 
typically developing siblings. They celebrate their children for their 
personality, temperament and abilities rather than their diagnosis. 
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Lantos and Meadow [33] agree that decisions should be made 
based on an individual infant’s response to treatment. Derrington and 
Dworetz [34] also emphasize an individualized approach coupled with 
understanding the values of each infant’s family. Information from 
medical professionals is used to arrive at decisions regarding medical 
interventions. Best interests of child re discussed with information 
from physicians about possible outcomes. It is unfortunate that 
the recommendations of Derrington and Dworetz [34] and Lantos 
and Meadow [33] are not followed as evidenced by Thiele’s [35] 
description of the circumstances she faced with her son with t18. 
What makes this case particularly discouraging was the absence of 
compassion after prenatal diagnosis of the condition. The author’s 
account illustrates the medical profession’s bias toward a paradigm of 
medical futility and placing minimal value on a life due to the child’s 
rare trisomy diagnosis. With the continued rise of prenatal testing, 
the end point of this perspective becomes increasingly disheartening. 
Making treatment decisions in the best interests of an infant 
cannot be effectively done with a “doom and gloom” orientation 
as is often the case toward this population. How can hope be held 
when a condition is characterized as “…lethal condition that [is] not 
curable by intensive care…” [27]? How can parents make decisions 
without counseling that incorporates a variety of outcomes and an 
appreciation for quality of life [36-38]? Quality of life is not solely ours 
to decide. It must be informed by all possible outcomes gleaned from 
valid research including parent perspectives on their living as well as 
deceased children. In this author’s experience with the TRIS project, 
the latter group voices an almost uniform point of view of the value of 
their child’s life regardless of how short, medical complications and 
the like.  
Merritt et al. [39] discuss decision making and the need for case-
by-case review as the basis for decision-making rather than broad 
recommendations. Nelson et al. [40] state “although diagnoses of 
trisomy 13 and 18 are generally assumed to be fatal within days to 
weeks after birth, a small but significant subgroup of children with 
trisomy 13 and 18 are alive over the age of 1 year, and at least some 
of these children receive substantial inpatient hospital care” (p. 874) 
Yates et al. [41] point to a shift in interventions to address cardiac 
anomalies based on parent request. Yet, the impact of these studies 
is minimized by empirical reports emphasizing early mortality [42]. 
At the present time, there is no definitive consensus on medical 
interventions and quality of life due to the reasons explained here. 
A greater effort to collect longitudinal data is a starting point. The 
TRIS project has up to six years of data for some children and adults 
(project began in 2007; parents complete annual updates on medical 
interventions, therapy services etc) There are no similar databases. 
There continues to be a reliance on adherence to the “gloom and 
doom” data cited in the literature [1,2,9,12,24,27] rather than a more 
balanced representation of possible outcomes [17,19,29,36].
Conclusion 
There is a need toward ethical case analysis for medical 
interventions and determining quality of life for children with 
t18 and t13 as described by Hentschel et al. [43]. The authors state 
“more attention should be focused on the parents’ information 
level and on their involvement in the decision-making process” 
(p. 568). This perspective, along with data indicating the success of 
medical interventions for this population [3,19,21,32,44,45] deserve 
greater study and consideration. In addition, changing thoughts on 
palliative care must be considered on behalf of this population [46]. 
As Fenton [47] explained, “How easy it is to assume we know what 
a good quality of life is for anyone other than ourselves. We assess 
the burdens of care, the impact on siblings, the impact on parental 
relationships, the impact on finances and the utilization of resources. 
We perform ethical analyses assuming we truly understand how to 
apply beneficence or maleficence to a child with trisomy 18 or 13 or 
any other disorder in which there may be profound disability. As 
if the child can tell us what he or she is feeling. But we can do our 
best to assess and treat pain and discomfort. Smiles and laughter 
need no score pad. We know what they mean. The advice we give 
may often be centered around our personal notions about quality of 
life… advocate for a willingness to do whatever it takes, however long 
it takes, however many consults and team members it takes to fully 
inform and understand the goals, values and aspirations parents may 
have for their children. Once we have done that we need to honor 
the parents by helping them achieve those goals whether it is comfort 
care alone, a full court press or something in between.” 
These along with directives established by the “…CRC and 
CRPD…as the comprehensive articulation of the rights of all 
individuals with disabilities including infants and young children” 
discussed by Brown and Guralnick [22] and coupled with Carey’s [48] 
recommendation for a “…balanced approach to counseling families 
of the newborn with trisomy 18 and 13 at the time of diagnosis and 
at decision points in management, that is, in the delivery room, 
newborn nursery and clinic” are words to guide decision making.
The present review was intended to provide a counterpoint to 
discussions of “incompatibility with life”, “lethal diagnoses” and 
a general unwillingness for “aggressive” interventions. Long-term 
survivors with rare trisomy conditions must be further studied so that 
recommendations for their care can be made on an informed basis 
rather than from a biased perspective inclined toward comfort care or 
palliative care. Quality of life needs to enter the equation informed by 
data and parent voices. Children like Annabel and Arianna deserve 
no less. 
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